about
Appetite suppressants and primary pulmonary hypertension in the United KingdomLow-dose fenfluramine in the treatment of neurologic disorders: experience in Dravet syndromeDNA Damage and Pulmonary HypertensionFenfluramine--induced irreversible pulmonary hypertensionIrreversible pulmonary hypertension after treatment with fenfluraminePrimary pulmonary hypertension and fenfluramine useDietary pulmonary hypertension.Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene.Advance modern medicine with clinical case reportsIdiopathic pulmonary arterial hypertension: an avian model for plexogenic arteriopathy and serotonergic vasoconstrictionMyocardial infarction associated with the use of dextrofenfluramine.Clemizole and modulators of serotonin signalling suppress seizures in Dravet syndrome.Management of primary pulmonary hypertensionPulmonary arterial hypertension: an overview.Epidemiology of pulmonary hypertension in the elderly.Pulmonary veno-occlusive disease: advances in clinical management and treatments.Stimulants and the lung : review of literature.Cardiovascular safety of low-dose fenfluramine in Dravet syndrome: a review of its benefit-risk profile in a new patient population.Insulin resistance in systemic hypertension: pharmacotherapeutic implications.Effective medical writing: How to write a case report which Editors would publishMonoclonal endothelial cells in appetite suppressant-associated pulmonary hypertension.Scleroderma after therapy with appetite suppressants. Report on four cases.Systolic pulmonary artery pressure and echocardiographic measurements in patients with euthyroid Hashimoto's thyroiditis.DRUG INDUCED PULMONARY ARTERIAL HYPERTENSION: A PRIMER FOR CLINICIANS AND SCIENTISTS.Irreversible pulmonary hypertension after treatment with fenfluramine.
P2860
Q24563207-29BCC8C3-B48D-4A1F-9AEC-6A374AD082EDQ26776222-CAFD086B-4763-4E22-A5B9-8A5D81639947Q27005594-655F8B71-AA2E-4D2B-B82B-831EF1C38D61Q28325081-CEAF1737-E5D6-4CD3-B0A0-58D1492AA7FFQ28360666-DD4E3BAB-FF0A-4527-8507-02462A2A737DQ28378428-48D72664-A7DA-4DC6-956C-658C172996C2Q33789022-152F986A-959E-4809-8B72-ADC6E63B7E86Q34142690-B76164A9-7079-4D9A-9E41-1B137585C7B0Q34633837-E35B97CA-5A6A-468B-8F2C-0223725269BBQ34913082-E80798DA-B095-4890-B5D6-B9400E60D9DBQ35170281-AD36AC7D-1A7A-4308-9D61-DB07916440D6Q36245909-BA9C82E7-850E-4499-A474-9C14167A62D4Q36754872-8E90CAA7-DC85-42D0-A836-9015E69A3CB2Q36834617-CCBF284F-640A-417A-94F9-6D5881683245Q37670921-0E0A4056-4C7A-48EE-972A-B38F9C4290BCQ37867672-35599A0A-3EE9-446C-9D14-52229AD8B6BDQ38113985-368C323E-D386-4378-961B-B93CAF721030Q38681023-E080F29E-7288-4F29-B6D3-7895D804FD62Q40949586-B36F9C92-D24C-4B8C-8AB7-A9C936642C01Q42348300-60D54FCD-D2C2-452B-81BF-9CF0871EE51CQ42537756-F4B9A72F-4EA4-40AD-AF42-2F1FB62A7B95Q45083333-6B7600D8-1EC6-478D-8B88-4ABF77A06380Q45993720-267A0AF7-76FF-479C-87A6-554900340CE8Q50124360-AE8DA29F-E3E5-4112-AFA5-F109C5D39526Q55174440-E60D31D7-5165-4948-A12A-C241F11F12F9
P2860
description
1981 nî lūn-bûn
@nan
1981 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1981 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1981年の論文
@ja
1981年論文
@yue
1981年論文
@zh-hant
1981年論文
@zh-hk
1981年論文
@zh-mo
1981年論文
@zh-tw
1981年论文
@wuu
name
Pulmonary hypertension and fenfluramine
@ast
Pulmonary hypertension and fenfluramine
@en
Pulmonary hypertension and fenfluramine
@nl
type
label
Pulmonary hypertension and fenfluramine
@ast
Pulmonary hypertension and fenfluramine
@en
Pulmonary hypertension and fenfluramine
@nl
prefLabel
Pulmonary hypertension and fenfluramine
@ast
Pulmonary hypertension and fenfluramine
@en
Pulmonary hypertension and fenfluramine
@nl
P2093
P2860
P3181
P356
P1433
P1476
Pulmonary hypertension and fenfluramine
@en
P2093
A H Kitchin
A T Proudfoot
J G Douglas
P2860
P3181
P356
10.1136/BMJ.283.6296.881
P407
P577
1981-10-03T00:00:00Z